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Abstract
Background: A double-blind, placebo-controlled, randomized study was performed to evaluate
the effect of oral creatine pyruvate (Cr-Pyr) and creatine citrate (Cr-Cit) supplementation on
exercise performance in healthy young athletes.
Methods: Performance during intermittent handgrip exercise of maximal intensity was evaluated
before (pretest) and after (posttest) 28 days of Cr-Pyr (5 g/d, n = 16), Cr-Cit (5 g/d, n = 16) or
placebo (pla, 5 g/d, n = 17) intake. Subjects performed ten 15-sec exercise intervals, each followed
by 45 sec rest periods.
Results: Cr-Pyr (p < 0.001) and Cr-Cit (p < 0.01) significantly increased mean power over all
intervals. Cr-Cit increased force during the first and second interval (p < 0.01) compared to
placebo. The effect of Cr-Cit on force decreased over time and the improvement was not
significant at the sixth and ninth interval, whereas Cr-Pyr significantly increased force during all
intervals (p < 0.001). Cr-Pyr (p < 0.001) and Cr-Cit (p < 0.01) resulted in an increase in contraction
velocity, whereas only Cr-Pyr intake significantly (p < 0.01) increased relaxation velocity. Oxygen
consumption measured during rest periods significantly increased with Cr-Pyr (p < 0.05), whereas
Cr-Cit and placebo intake did not result in significant improvements.
Conclusion: It is concluded that four weeks of Cr-Pyr and Cr-Cit intake significantly improves
performance during intermittent handgrip exercise of maximal intensity and that Cr-Pyr might
benefit endurance, due to enhanced activity of the aerobic metabolism.
Background
Creatine monohydrate supplementation has been found
to enhance high intensity intermittent athletic perform-
ance [1]. Long-term creatine supplementation increases
the effects of resistance training on muscle volume,
strength and power [2,3]. Short-term creatine supplemen-
tation results in an increase of muscle force and power
output during intermittent exercise, even in the absence of
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resistance training [4,5]. Facilitated muscle phosphocreat-
ine resynthesis [6] and more rapid and efficient recovery
periods [5,7] have been stated as proposed mechanisms
for this ergogenic effect. However, a majority of studies
suggest that creatine supplementation does not improve
endurance exercise capacity [8,9]. The effect of creatine
supplementation can be highly variable amongst individ-
uals [10] and low initial muscle creatine content has been
found to be a prerequisite for maximum ergogenic effects
[6,11]. Total muscle creatine concentration can be
increased by approximate 20% using a loading dose of 20
g/d for 6 days followed by a maintenance dose of 2 g/d
[12]. A more gradual increase can be achieved by 28-days
of low dose (3 g/d) supplementation [12], however, stud-
ies examining the effect of slowly loading the muscle with
creatine (3 g/d for six weeks [13], 1 g/d or 5 g/d for 10
weeks [14]) on exercise performance showed no signifi-
cant effect over placebo.
Combining creatine, a weak base which is usually
ingested in the form of creatine monohydrate, with an
acid intended to boosting endurance exercise capacity
such as pyruvic acid, could ultimately benefit athletes
involved in sports combining endurance and high inten-
sity exercise. High-dose pyruvate intake in combination
with dihydroxyacetone can positively influence endur-
ance exercise capacity [15]. Low-dose, short-term supple-
mentation of an inorganic pyruvate salt failed to increase
endurance capability measured by the critical power test
(8.1 g/d) [16], failed to increase endurance performance,
and had no significant effect on energy metabolism dur-
ing exercise in well-trained cyclists (7 g Ca-pyruvate per
day for 7 days) [17], questioning the efficacy of short-
term, low-dose pyruvate administration. The delivery of
orally ingested pyruvate to the skeletal muscle is probably
small due to partial decarboxylation in the stomach and
small intestine, and rapid clearance by the liver to be used
as a gluconeogenic precursor [17]. However, long-term
pyruvate (6 g pyruvate per day for 28 days) intake has
been found to increase plasma pyruvate concentration by
60% (n = 3) [18]. Citric acid might be another suitable
candidate since citrate supplementation has been found
to increase performance in intense exercise lasting
between 2 and 50 min, a duration in which the aerobic
metabolism becomes more important [19,20]; however,
no conclusive evidence exists that citrate supplementation
is able to increase endurance exercise capacity.
A recent bioavailability study on one-time creatine pyru-
vate (Cr-Pyr) and tri-creatine citrate (Cr-Cit) supplemen-
tation showed a significant increase in creatine plasma
levels with Cr-Pyr in comparison to creatine monohydrate
[21]. Two studies investigating endurance exercise capac-
ity of short-term Cr-Pyr supplementation showed mixed
results. 7 days of 7 g per day Cr-Pyr supplementation did
not beneficially impact endurance capacity or intermittent
sprint performance in well-trained cyclists [22], whereas 5
days of 7.5 g per day Cr-Pyr intake increased paddling
speed and resulted in decreased lactate concentrations in
Olympic canoeists suggesting an increase in aerobic
metabolism [23]. A combination of creatine monohy-
drate and calcium pyruvate was not more effective than
creatine monohydrate supplementation to enhancing
maximum strength and power during 5-weeks of in-sea-
son college football training [24]. High-dose, short-term
Cr-Cit supplementation (4 × 5 g Cr-Cit per day for 5 days)
has been found to increase anaerobic working capacity
(AWC) in healthy physically active women [25] and is
able to delay the onset of neuromuscular fatigue during
cycle ergometry [26].
This study investigates the effects of 28-days of Cr-Pyr, Cr-
Cit or placebo supplementation on endurance capacity
and intermittent handgrip power in healthy young ath-
letes using a daily dose intended to slowly load the muscle
with creatine (5 g/d of Cr-Pyr or Cr-Cit, equaling approx-
imate 3 g/d of creatine). Intermittent handgrip exercise of
maximal intensity is an exercise that combines endurance
as well as high intensity elements. This kind of exercise
allows investigating the effects of Cr-Pyr and Cr-Cit sup-
plementation to boosting power and endurance exercise
capacity.
Methods
Subjects
Forty-nine healthy male subjects participated in this
study. All subjects in this investigation participated in a
familiarization session. During the familiarization ses-
sion, subjects were informed as to the experimental proce-
dures, completed a personal/medical history form,
creatine supplementation history form and signed
informed consent statements in adherence with the
human subject's guidelines of the American College of
Sports Medicine. The study was approved by the Ethical
Review Committee of the University of Paderborn. Sub-
ject characteristics are presented in Table 1. No subject in
this trial was a vegetarian with all subjects reportedly con-
suming meat in their daily diet. Exclusion criteria on
admission were creatine supplementation within a period
of 3 months prior to the experiments or the intake of any
other nutritional supplement or medication at the time of
the study. The subjects were instructed to avoid changes in
their diet and training habits during the study.
Study Protocol
A double-blind, placebo-controlled study was performed
over a period of 5 weeks. The subjects performed 3 exer-
cise tests at the same time of the day (day 1: incremental
test, day 8: pre-test, day 35: post-test).Journal of the International Society of Sports Nutrition 2008, 5:4 http://www.jissn.com/content/5/1/4
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Choice of muscle group and type of exercise
Handgrip exercise is a simple movement with low
dependence on coordination. The exercise targets a spe-
cific muscle group while the use of auxiliary muscles is
excluded. During exercise of this muscle group, blood
samples from the working muscles can easily be taken
from a cubital vein [27]. The tone of the sympathetic
nerve system [28] and the composition of the arterial
blood remain almost unchanged. Any change of a param-
eter of cubital venous blood can almost exclusively be
attributed to the working muscles. Thus, differences
between the trials can be interpreted as consequences of
the different supplementations on muscle metabolism.
Incremental test
Handgrip exercise was performed with the arm stretched
in a horizontal position. The hand was lying on the hand-
grip and the arm was supported under the elbow. All sub-
jects had to use the right hand in this exercise. The
handgrip was connected to a basket that could be loaded
with variable weights. Displacement of the weights -at
maximum 3 cm- was recorded through an inductive
device connected to the basket (see Figure 1). The seat and
the arm support were adjusted for each subject to main-
tain a constant angle at the shoulder between subjects.
Maximum forearm performance was measured starting at
a weight of 7.5 kg. The weight was increased by 2.5 kg
every 3 minutes until subjective fatigue of the muscle
group. The contraction frequency was 24 times per
minute. A metronome was placed in sight of the subject to
facilitate sustaining the correct contraction frequency.
Pre and post-test
After an overnight fast the subjects reported to the lab and
their anthropometrical data was taken (age, height, body
weight, body fat (measured by bioelectrical impedance
analysis) and forearm circumference). Afterwards, blood
was sampled from a cubital vein to determine kidney
function (creatinine, urea), fat metabolism (free fatty
acids, Cholesterol (total, HDL, LDL)) and liver function
(gamma GT, OT, PT). Exercise started 45 min after blood
sampling and after having a standardized light breakfast
consisting of two rolls and jam (see Figure 2).
To test the effects of Cr-Pyr and Cr-Cit the subjects per-
formed intermittent, dynamic handgrip exercise of high
intensity. The weight of the basket was 80% of the maxi-
mum weight reached in the incremental test. The subjects
were instructed to squeeze the handgrip as many times as
possible during a 15 sec exercise period. Ten intervals were
carried out separated by breaks of 45 sec. A fan was placed
above the forearm to reduce skin blood flow by cooling.
Blood samples were taken before and after the 1st, 2nd, 6th,
9th and 10th interval from a cubital vein. Blood hemo-
globin ([Hb]) and oxy-hemoglobin concentrations
([HbO2], OSM III, Radiometer, Copenhagen) as well as
hematocrit (Hct, microcentrifugation at 19500 g, Biofuge,
Schematic presentation of the experimental set up Figure 1
Schematic presentation of the experimental set up. 
The working arm was in a horizontal position supported 
under the elbow. The handgrip had to be squeezed with the 
highest contraction frequency possible. The maximum dis-
placement was 3 cm. The fan was used to reduce skin blood 
flow by cooling.

elbow support
fan
adjustable seat
handgrip
 weights
inductive device
 computer
Table 1: Anthropometrical data and blood values after overnight fast
Cr-Pyr P Value (pre/post) Cr-Cit P Value (pre/post) Pla P Value (pre/post)
Age (years) 26.8 ± 3.6 26.7 ± 4.4 26.3 ± 4.5
Height (cm) 184.4 ± 4.9 182.7 ± 6.2 180.2 ± 5.4
Bodyweight (kg) pre 81.7 ± 10.9 < 0.001 78.1 ± 9.0 < 0.001 77.6 ± 7.3 n.s.
post 83.2 ± 10.7 79.5 ± 9.2 77.7 ± 7.3
Body Fat (%) pre 16.7 ± 4.6 n.s. 15.0 ± 4.3 n.s. 15.0 ± 5.2 n.s.
post 16.6 ± 4.8 14.7 ± 3.9 14.8 ± 7.3
Forearm circumference 
(cm)
pre 29.0 ± 2.2 < 0.05 28.1 ± 1.5 < 0.001 28.3 ± 1.2 n.s.
post 29.7 ± 2.2 28.6 ± 1.5 28.6 ± 1.2
Creatine (µmol/l) pre 94.7 ± 5.5 < 0.001 98.8 ± 8.4 < 0.05 93.1 ± 9.0 n.s.
post 105.1 ± 6.7 108.3 ± 14.1 93.5 ± 8.5
Means ± SD, n.s. = not significant.Journal of the International Society of Sports Nutrition 2008, 5:4 http://www.jissn.com/content/5/1/4
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Hereaus) were measured. Arterio-venous difference in
oxygen (a-vDO2) was calculated assuming an oxygen sat-
uration of 95% in the arterial blood. Lactate concentra-
tion ([Lac]) was measured polarimetrically in cubital
venous blood (Biosen 5030, EKF Barleben, Germany).
Ammonia concentration [NH3] was determined in
plasma (test no. 1877984, Roche, Mannheim, Germany).
In order to calculate NH3-release it was assumed that arte-
rial [NH3] remained constant during the present exercise
protocol. The fraction of NH3 entering the red cells was
neglected. Blood flow was measured by venous occlusion
plethysmography during the recovery periods between
intervals 6 and 7.
Calculation of mechanical data
The first 3 contractions of each interval were discarded
because some of the subjects adjusted the position of their
hand. Work per contraction (J) was calculated from the
displacement and the lifted weight. Total work was calcu-
lated from the sum of work of each contraction performed
in the first, second, sixth and ninth interval. Mean power
was calculated as total work divided by the time evalu-
ated. Contraction velocity was calculated from displace-
ment and contraction time. In the same way, relaxation
velocity was calculated. Force was calculated from the
contraction velocity and the lifted weight. The 10th inter-
val was excluded from the evaluation as subjects often
used additional muscles (movements of upper body) dur-
ing the last interval.
Experimental conditions
The subjects were assigned in random order to either the
Cr-Pyr (n = 16), the Cr-Cit (n = 16) or the placebo (pla, n
= 17) group. It was attempted to match groups for body
mass/height ratio and the maximum weight achieved in
the incremental test. Athletes with a high degree of hand-
grip utilization (martial arts, wrestling, etc) could possibly
benefit to a greater degree due to training effect, as
opposed to sports that neglect the upper extremity/hand
grip (track, soccer, etc). To avoid potential differences
between groups, athletes with a high degree of handgrip
utilization have been equally distributed between groups.
The 28-day supplementation period was started immedi-
ately after the pre-test and was continued until the day
before the post-test. Subjects either received Cr-Pyr
(Creapure™ Pyruvate, Degussa, Germany, containing 60%
creatine and 40% pyruvate) or Cr-Cit (Creapure™ Citrate,
Degussa, Germany, containing 65% creatine and 35% cit-
rate) in form of lemon flavored effervescent tablets at a
dose of 5 g per day, while the others received correspond-
ing placebo supplements. Cr-Pyr and Cr-Cit contained
<100 ppm creatinine, whilst dicyandiamide and dihyrdo-
triazine levels and polymeric pyruvates in CrPyr were not
detectable by HPLC. The subjects were instructed to take
the effervescent tablets (2 in the morning, 1 at noon and
2 in the evening) after the main meals accompanied by a
carbohydrate rich drink. Intake of coffee and soft drinks
containing caffeine was restricted to two cups a day.
Forearm exercise started 45 min after the first blood sample had been taken Figure 2
Forearm exercise started 45 min after the first blood sample had been taken. Exercise consisted of 10 maximal 
bouts of 15 sec separated by a 45 sec rest period. Timing of blood samples are indicated by small arrows (open arrow: pre 
exercise sample; filled arrow: post exercise sample).
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Statistics
Group data were expressed as mean ± SD and statistical
significance was set at the p < 0.05 level. Subjects' charac-
teristics before the investigation were compared using
ANOVA. Pre and Post differences of anthropometric data
and total means were analyzed by two-way ANOVA for
repeated measures with post-hoc t-test considering the
multi-comparison problem (Holm-Sidak). Force and
relaxation velocity was analyzed by three-way ANOVA. In
case of significant main effects for the treatment the effects
within the groups were separately analyzed by a two-way
ANOVA with repeated measurement in both factors.
Results
Anthropometric data and blood parameters
Body weight increased in both creatine groups by a similar
amount (p < 0.001, Table 1), whereas the weight in the
placebo-group remained unchanged. Circumference of
the forearm increased significantly in both creatine groups
(p < 0.01, Table 1). Cr-Pyr and Cr-Cit were well tolerated.
Creatinine levels increased significantly in both creatine
groups but remained within the normal range. Data for all
other measured blood parameters were in the normal
range and no difference between groups could be deter-
mined.
Performance data
The pre-test performance data was not statistically differ-
ent among all groups. Supplementation with Cr-Pyr (p <
0.001) and Cr-Cit (p < 0.02) resulted in a significant
increase in mean power (see Figure 3), while the placebo
group showed no increase in power. A-vDiff in O2
increased insignificantly (p > 0.05) in both creatine
groups. The oxygen uptake to mean power ratio was
slightly reduced with Cr-Cit and Cr-Pyr, however, the
changes were not statistically significant (p > 0.05, Figure
3). Blood flow was enhanced with Cr-Pyr but decreased
slightly with Cr-Cit, however, both were not statistically
significant (p > 0.05). A-vDiff in O2 and blood flow meas-
ured during the recovery periods significantly increased (p
< 0.05) in the Cr-Pyr group concordantly with muscular
oxygen consumption compared to the pre-tests. Venous
blood lactate levels remained unchanged with either treat-
ment. Mean muscular NH3  release was significantly
reduced in the Cr-Cit group (p < 0.05). The NH3 release
per unit of power decreased after Cr-Pyr and Cr-Cit treat-
ments, conversely, only Cr-Cit group resulted in signifi-
cant changes (p < 0.015, Figure 3).
The contraction velocity increased 24% with Cr-Pyr (p <
0.01) and 20% with Cr-Cit (p < 0.01, Table 2). This
increase is accompanied by a significant increase in force
(p < 0.001) and relaxation velocity (p < 0.01) in the Cr-
Pyr group. The Cr-Cit group showed a significant increase
in force (p < 0.01), however, the change in relaxation
velocity was not significant. In addition, Cr-Cit signifi-
cantly increased force only during the first two intervals,
when compared to placebo. The effect of Cr-Cit on force
decreased over time and the improvement was not signif-
icant at interval 6 and 9. The increase in contraction fre-
quency is the major reason for the increase in mean
power.
Discussion
Main findings
The results of this study suggest that 4 weeks of low dose
Cr-Pyr and Cr-Cit intake significantly increased mean
power in comparison to placebo. Cr-Pyr improved con-
traction velocity and reduces fatigability during intermit-
tent exercise of high intensity. Cr-Pyr showed significant
improvements in force during all intervals, whereas the
effects of Cr-Cit decreased and improvements were not
significant during the later intervals. The effect of Cr-Pyr
resulted from an increased contraction and relaxation
speed and is accompanied by enhanced oxygen consump-
tion and blood flow.
Effects on body weight
Daily creatine intake ranged from 0.027 to 0.047 g/kg bw
(mean 0.037) in the Cr-Pyr group and from 0.036 to
0.052 g/kg bw (mean 0.044) in the Cr-Cit group. Despite
a 19% difference in mean creatine dosage per body weight
there was a similar increase in body weight in both creat-
ine groups without significant changes in body fat. Weight
increased in 15 of 16 subjects (94%) with Cr-Pyr and in
14 of 16 subjects (88%) with Cr-Cit. The weight gain is
similar to previously reported weight gains of short-term,
high-dose [6,29] or long-term, low-dose creatine supple-
mentation [12].
Performance enhancement during the first interval
The efficacy of creatine during the first exercise interval is
dependent on the type, the intensity and the duration of
exercise. The exercise must be of high intensity and of a
certain duration allowing PCr stores to drop significantly.
Additionally, the efficacy of creatine supplementation
seems to be dependent on the speed of movement. Dur-
ing isometric exercise, creatine supplementation was
found to have no or small effects on isometric torque pro-
duction [30,31]. An increase in power of about 20% was
measured in fast movements using Wingate tests [32] and
isokinetic tests resulted in moderate improvements of
mean and peak power (6% and 8%, respectively) [33]. Cr-
Cit and Cr-Pyr supplementation increase performance
during the first intervals (see Table 2) in contrast to previ-
ously published data [5,34]. The increase of Cr-Pyr group
was larger compared to the Cr-Cit group; however, the dif-
ference was not significant. The type of exercise used in
this study consisted of a large amount of negative work. If
only the active work is considered (contraction velocity, asJournal of the International Society of Sports Nutrition 2008, 5:4 http://www.jissn.com/content/5/1/4
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the reduction of the displacement can be neglected in the
first interval), the improvement is 18 and 15%, respec-
tively, an increase comparable to studies using Wingate
tests.
The increase in performance in both creatine groups at the
beginning of the intermittent exercise is related to an
increased contraction speed. Contraction speed during
fatiguing exercise seems to be reduced when free ADP
increases [35]. Creatine has been reported to increase ATP
re-synthesis and thus reduce the increase in free ADP [36].
This is confirmed by smaller muscular NH3 release during
exercise which suggests a lower adenosine (AMP) to inos-
ine (IMP) conversion rate (ATP dependent), and thus
lower inorganic phosphate concentration. A reduced NH3
release or concentration in blood was shown in previous
creatine supplementation studies [33,37]. Creatine sup-
plementation results in reduced hypoxanthine concentra-
tions [37] which might be the explanation for the
observed improvement in the first interval with Cr-Cit
and Cr-Pyr. Relaxation speed increased in both Creatine
groups after the first exercise interval comparable to previ-
ous observations [31]. But the increase was only signifi-
cant with Cr-Pyr.
Performance during repeated intervals
The effect of creatine supplementation on performance in
repeated intervals varies with the diversity of tests and the
beneficial effect decrease at later intervals of the exercise.
Short-term, high-dose creatine supplementation did show
the greatest improvement in performance between inter-
vals 4 and 7 during 10 intervals of 6 sec maximum cycling
exercise [34]. Subsequent intervals showed a decrease in
improvement [34]. Thirty sec exercises intervals resulted
in a decrease of improvement in performance from the
second interval [36], showed no improvement in the third
interval [33], or no difference in the fourth and fifth inter-
val [5]. The beneficial effect of creatine intake on interval
exercise was related to an increased rate of PCr re-synthe-
sis during breaks [6,38] but the existing literature is incon-
clusive. PCr re-synthesis was found not to be enhanced
[38] or even reduced [39] and the rate of synthesis defined
as dPCr*s-1 after dynamic [38] and isometric work [31]
was not influenced by creatine supplementation. Cycling
with maximal intensity for 30 sec resulted in decreased
PCr levels of 49 mmol kg-1 dry weight without and 57
mmol kg-1 dry weight with creatine ingestion [36]. How-
ever, the difference in re-synthesis after exercise was only
2 mmol after 4 min [36] indicating an enhanced accumu-
lation of inorganic phosphate (Pi) during repeated inter-
vals, especially if the breaks are short. Increased Pi might
cause fatigue [40] which might be compensated by an
increased PCr pool during early intervals. PCr decreases
during later intervals [33] and is not able to compensate
the effects of increased Pi. The decrease in performance
relative to the initial performance might be greater after
creatine supplementation [5,31,33,36]. Cr-Cit intake
showed such a performance pattern (see Table 2) indicat-
ing that fatigue occurred in parallel to PCr-breakdown
[41]. If PCr re-synthesis would have been increased after
creatine ingestion, Pi concentration should not increase.
As a result, ATP production must be enhanced resulting in
an increased oxygen uptake during the breaks. Compara-
ble to previous research did Cr-Cit supplementation not
Top: Mean power over all evaluated intervals was signifi- cantly improved with Cr-Pyr and Cr-Cit; middle: ratio of  mean oxygen to mean power; bottom: Cr-Cit significantly  improves ratio mean ammonia release to mean power (Left:  pre supplementation, right: post supplementation, *** P <  0.001; * <0.02) Figure 3
Top: Mean power over all evaluated intervals was sig-
nificantly improved with Cr-Pyr and Cr-Cit; middle: 
ratio of mean oxygen to mean power; bottom: Cr-
Cit significantly improves ratio mean ammonia 
release to mean power (Left: pre supplementation, 
right: post supplementation, *** P < 0.001; * <0.02).
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change oxygen uptake. Therefore the ratio VO2 to mean
power decreased slightly (see Figure 3), indicating that the
additional energy was derived from anaerobic sources and
that PCr re-synthesis was not enhanced.
The increase in performance with Cr-Pyr during the first
intervals is slightly larger than with Cr-Cit. Moreover, Cr-
Pyr reduces fatigability during all following intervals. The
improvement results from an increase in contraction
velocity during all intervals and an increase in relaxation
velocity [31]. This suggests ADP or Pi levels are reduced
and ATP re-synthesis is increased during exercise, which
should lead to an increased VO2. In fact, the improvement
in performance is accompanied by an increase in muscu-
lar VO2  measured during the breaks. As blood flow
decreases during the 15 sec of exercise due to the high
forces occurring [42], muscular oxygen uptake during
exercise cannot be very high. Therefore, measurements
during the breaks are representative for the oxygen con-
sumption during the exercise period. The ratio VO2 to
mean power drops similar to Cr-Cit indicating that most
of the improvement is due to the increased VO2, however
a small amount of energy is still derived from anaerobic
sources. The energy must be derived from phosphate
stores since lactate levels did not change. The amount is
comparable to that observed after the Cr-Cit supplemen-
tation. The additional amount of aerobic work after Cr-
Pyr supplementation compensates the creatine effect on
ammonia release as the ratio ammonia release to mean
power is not significantly different between pre and post-
tests. Thus the improvement by Cr-Pyr seems to be caused
by a different mechanism perhaps resulting in increased
ADP concentration compared to Cr-Cit.
Possible reasons for the increased aerobic metabolism
A potential creatine effect on the time course of VO2 is
related to Phosphocreatine breakdown (Bessman cycle or
Phospho-Creatine shuttle) [43]. Cr-Cit and Cr-Pyr supple-
mentation should result in a similar increase in muscle
creatine content; hence varieties in VO2  cannot be
explained by differences in the Bessman cycle. Addition-
ally, there are some studies showing that VO2 during exer-
cise is unaffected [9], or the VO2-kinetics is even slowed
down after creatine supplementation [44] and oxygen
consumption after exercise of high intensity or during
breaks is unchanged [45].
The observed results suggest additional pyruvate benefits
in the Cr-Pyr group. The role of pyruvate supplementation
might be to decrease the relative inhibition on aerobic gly-
colysis due to elevated creatine phosphate and ATP levels.
It may also be reflective of a more rapid regeneration of
ATP and reduction in the inorganic phosphate increase,
allowing for higher intracellular calcium ion concentra-
tion, permitting the higher frequency contraction and
relaxation. To achieve an additional effect of pyruvate an
increase in plasma pyruvate concentration should occur.
A recent study showed that one-time administration of 5
g Cr-Pyr does not increase plasma pyruvate concentra-
tions [21]. However, previous research found a cumula-
tive effect of pyruvate administration increasing the
plasma pyruvate concentration by about 60% after 4
Table 2: Force and relaxation velocity.
Interval 1 Interval 2 Interval 6 Interval 9
Cr-Pyr
Force (N) pre 209 ± 47 202 ± 47 202 ± 50 204 ± 52
post 218 ± 48** 212 ± 49** 212 ± 52** 213 ± 49**
Relaxation Velocity (m/s) pre 0.151 ± 0.033 0.141 ± 0.032 0.143 ± 0.046 0.150 ± 0.040
post 0.164 ± 0.019* 0.158 ± 0.025* 0.163 ± 0.034* 0.166 ± 0.032*
Cr-Cit
Force (N) pre 191 ± 53 184 ± 51 184 ± 54 184 ± 55
post 198 ± 54* 193 ± 54* 188 ± 54‡ 188 ± 55‡
Relaxation Velocity (m/s) pre 0.154 ± 0.020 0.135 ± 0.033 0.135 ± 0.033 0.137 ± 0.035
post 0.169 ± 0.034‡ 0.142 ± 0.023‡ 0.135 ± 0.026‡ 0.140 ± 0.027‡
Placebo
Force (N) pre 180 ± 45 173 ± 43 171 ± 44 171 ± 39
post 182 ± 42‡ 176 ± 41‡ 173 ± 38‡ 174 ± 39‡
Relaxation Velocity (m/s) pre 0.155 ± 0.031 0.139 ± 0.036 0.131 ± 0.048 0.146 ± 0.062
post 0.160 ± 0.032‡ 0.142 ± 0.037‡ 0.146 ± 0.047‡ 0.152 ± 0.049‡
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weeks [18]. In the intestine and the liver, pyruvate can eas-
ily be converted to ketone compounds [46] or different
amino acids [47]. If parts of these substances or of the
pyruvate absorbed were distributed to the muscle the pool
of substances for anaplerotic reactions would increase.
This enables the muscle to replenish the pool of tri-car-
bon-cycle intermediates rapidly at the beginning of exer-
cise. This replenishment might favor the flux through the
TCA cycle and thus increase the delivery of protons to the
respiratory chain. The increased concentration of interme-
diates might also act as a pyruvate buffer, with the func-
tion to deliver carbon skeletons to the TCAC. Both
mechanisms could be beneficial during the transition
from rest to high intensity exercise to increase oxygen
uptake [48]. Given the transient presence of anaplerotic
substrates, the effect might be short-lived and not subject
to long-term accumulation over time. The results of more
acute administration or different organic salts of pyruvate
would be of interest.
Conclusion
Cr-Cit and Cr-Pyr supplementation significantly increases
mean power in high intensity exercise. Cr-Pyr intake sig-
nificantly increases force and decreases fatigability during
all intervals due to an enhanced contraction and relaxa-
tion velocity. The performance with Cr-Cit decreases with
time and improvements were not significant during the
later intervals. Further research is required to exam the
mechanism of decreasing fatigue during intermittent exer-
cise of high intensity observed with Cr-Pyr intake.
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